查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1750649

登革熱檢測市場規模、佔有率、趨勢分析報告：按產品類型、服務類型、最終用途、地區和細分市場預測，2025 年至 2030 年

Dengue Testing Market Size, Share & Trends Analysis Report By Product, By Service Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 195 Pages | 商品交期: 2-10個工作天內

價格

登革熱檢測市場的成長與趨勢

根據Grand View Research, Inc.的最新報告，全球登革熱檢測市場規模預計到2030年將達到8.2261億美元，2025-2030年期間的複合年成長率為5.22%。

都市化、氣候變遷和國際旅行增加等因素正在擴大家貓的棲息地，而家貓是傳播登革熱的主要蚊媒。例如，2023年印度報告了近30萬例登革熱病例，凸顯了亞太地區登革熱疫情的日益嚴重。發病率的上升迫切需要開發和部署高效的診斷工具，以便早期發現和快速治療，從而降低與疾病相關的發病率和死亡率。

診斷技術的創新顯著提高了登革熱檢測的準確性和速度。酵素結合免疫吸附檢測法(ELISA)、逆轉錄聚合酵素鏈鎖反應(RT-PCR) 和快速抗原檢測等先進方法的引入，徹底改變了這一領域。這些技術具有高靈敏度和特異性，使醫療保健提供者能夠快速診斷登革熱感染。此外，就地檢驗設備的開發促進了現場診斷，這在偏遠和資源匱乏的地區至關重要。這些進步不僅改善了患者的預後，也有助於遏止感染的傳播。

政府和國際合作在加強登革熱檢測市場方面發揮關鍵作用。 2024年8月，美國國際開發署(USAID) 向加勒比海公共衛生署 (CARPHA) 捐贈了價值2萬美元的登革熱和其他蟲媒病毒檢測套組，以加強該地區的疫情應對。此類舉措彰顯了加強脆弱地區診斷能力的承諾。此外，美國食品藥物管理局(FDA) 等監管機構正在加快核准創新診斷解決方案，例如生物梅里埃的 BIOFIRE FILMARRAY 熱帶發熱檢測組，該檢測組於2024年12月獲得了510(k) 特別許可。這些協同努力將擴大先進診斷工具的全球覆蓋率和利用率。

隨著人們對登革熱及其影響的認知不斷提高，診斷檢測的需求也隨之增加。公共衛生宣傳活動和教育計畫幫助社區了解了登革熱的症狀、傳播和預防方法。這種認知鼓勵人們及時就醫，從而需要高效率的診斷服務。此外，知情的社區更有可能參與病媒控制活動，間接促進疾病控制。因此，重視教育和宣傳在推動診斷市場發展方面發揮關鍵作用。

快速診斷檢測 (RDT)套件的開發和普及徹底改變了登革熱的檢測方式，尤其是在流行地區。這些套件通常可在幾分鐘內快速提供結果，有助於臨床快速做出決策。 2023 年 8 月，富士軟片推出了其突破性的登革熱 NS1 抗原檢測套組，該試劑盒採用專有的銀擴增技術，可實現早期診斷。此類技術創新對於降低疾病嚴重程度和死亡率至關重要。 RDT 的便利性、經濟性和高效性使其成為全球對抗登革熱的重要工具，從而推動了市場成長。

登革熱檢測市場報告重點

  • 根據產品，基於 ELISA 的檢測領域將在 2024 年佔據最大的市場佔有率，達到 44.94%，這得益於高靈敏度、特異性以及檢測登革熱抗原 (NS1) 和抗體 (IgM 和 IgG) 的能力。
  • 根據服務類型，對準確和全面的檢測解決方案的需求不斷成長，使集中服務部門在 2024 年以 59.93% 的收入佔有率引領市場。集中實驗室主要設立在醫院和診斷中心，提供先進的診斷能力，例如 ELISA 和 RT-PCR 測試，這對於確認登革熱感染至關重要。
  • 根據最終用途，臨床檢測領域佔據市場主導地位，2024 年的收入佔有率為 44.16%。成長的動力來自於實驗室自動化、高通量 ELISA 和 RT-PCR 平台的投資不斷增加，這些平台可實現當天的周轉時間。
  • 2024年，亞太地區以31.57%的市佔率領先全球市場，主要得益於印度、印尼和泰國的登革熱疫情。國家媒介控制計畫（例如印度的NVBDCP）為當地實驗室提供ELISA和RT-PCR檢測資金，而當地衛生中心則部署了POC NS1快速檢測。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 登革熱檢測市場變數、趨勢和範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場趨勢與展望
  • 市場動態
    • 登革熱發生率上升
    • 技術進步
    • 政府和國際努力
  • 市場限制因素分析
    • 診斷測試成本高昂
    • 醫療基礎設施使用受限
    • 波特五力分析
    • PESTEL分析

第4章 登革熱檢測市場：產品、估值與趨勢分析

  • 登革熱檢測市場：產品差異分析
  • 按產品
  • 基於 ELISA 的檢測
  • 登革熱 IgG/IgM 檢測套件
  • RT-PCR檢測
  • 快速診斷測試（RDT）
  • NS1抗原檢測套件
  • 側流免疫檢測

5. 登革熱檢測市場（按服務類型、估算和趨勢分析）

  • 登革熱檢測市場：服務類型變化分析
  • 按服務類型
  • 集中服務
  • POC服務

6. 登革熱檢測市場：最終用途、預估及趨勢分析

  • 登革熱檢測市場：最終用途變異分析
  • 按最終用途
  • 臨床實驗室
  • 醫院/診所
  • 家庭醫療保健

7. 登革熱檢測市場：區域、估計和趨勢分析

  • 2024 年及 2030 年登革​​熱檢測市場佔有率（按地區）
  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 2018-2030年北美登革熱檢測市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030年歐洲登革熱檢測市場
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030年亞太地區登革熱檢測市場
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 2018-2030年拉丁美洲登革熱檢測市場
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2018-2030年中東及非洲登革熱檢測市場
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司分類
  • 戰略地圖
  • 2024年公司市場佔有率分析
  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • Abbott
    • F. Hoffmann-La Roche Ltd.
    • InBios International, Inc.
    • NovaTec Immundiagnostica GmbH
    • Abnova Corporation
    • PerkinElmer Inc.（Euroimmun AG）
    • Certest BIoTec
    • DiaSorin SpA
    • Quest Diagnostics Incorporated
Product Code: GVR-4-68040-589-8

Dengue Testing Market Growth & Trends:

The global dengue testing market size is expected to reach USD 822.61 million by 2030, registering a CAGR of 5.22% from 2025 to 2030, according to a new report by Grand View Research, Inc. Factors such as urbanization, climate change, and increased international travel have expanded the habitats of Aedes mosquitoes, the primary vectors for dengue transmission. For instance, in 2023, India reported nearly 300,000 dengue cases, highlighting the disease's growing prevalence in Asia-Pacific region. This escalating incidence necessitates the development and deployment of efficient diagnostic tools to enable early detection and prompt treatment, thereby reducing morbidity and mortality associated with the disease.

Innovations in diagnostic technologies have significantly improved the accuracy and speed of dengue detection. The introduction of advanced methods such as enzyme-linked immunosorbent assays (ELISA), reverse transcription-polymerase chain reaction (RT-PCR), and rapid antigen tests has revolutionized the field. These technologies offer high sensitivity and specificity, enabling healthcare providers to diagnose dengue infections promptly. Moreover, the development of point-of-care testing devices facilitates on-site diagnostics, crucial in remote or resource-limited settings. Such advancements not only enhance patient outcomes but also contribute to controlling the spread of the disease.

Governmental and international efforts play a pivotal role in bolstering the dengue testing market. In August 2024, the United States Agency for International Development (USAID) donated dengue and other arbovirus test kits, valued at USD 20,000, to the Caribbean Public Health Agency (CARPHA) to enhance regional outbreak response. Such initiatives underscore the commitment to strengthening diagnostic capacities in vulnerable regions. Additionally, regulatory bodies like the U.S. Food and Drug Administration (FDA) have expedited the approval of innovative diagnostic solutions, such as bioMerieux's BIOFIRE FILMARRAY Tropical Fever Panel, which received Special 510(k) clearance in December 2024. These concerted efforts facilitate the availability and adoption of advanced diagnostic tools globally.

Heightened awareness about dengue fever and its implications has led to increased demand for diagnostic testing. Public health campaigns and educational programs have been instrumental in informing communities about the symptoms, transmission, and prevention of dengue. This awareness encourages individuals to seek timely medical attention, thereby necessitating efficient diagnostic services. Furthermore, informed communities are more likely to participate in vector control initiatives, indirectly contributing to disease management. The emphasis on education and awareness thus plays a critical role in driving the diagnostics market.

The development and availability of rapid diagnostic test (RDT) kits have transformed dengue detection, especially in endemic regions. These kits offer quick results, often within minutes, facilitating immediate clinical decisions. In August 2023, Fujifilm launched its revolutionary Dengue NS1Ag Test Kit, utilizing proprietary silver amplification technology to enable early diagnosis. Such innovations are crucial in mitigating disease severity and reducing mortality rates. The convenience, affordability, and efficiency of RDTs make them indispensable tools in the global fight against dengue, thereby propelling market growth.

Dengue Testing Market Report Highlights:

  • Based on product, the ELISA-based tests segment accounted for the largest market share of 44.94% in 2024, driven by their high sensitivity, specificity, and ability to detect both dengue antigens (NS1) and antibodies (IgM and IgG).
  • Based on service type, the centralized service segment led the market with a 59.93% revenue share in 2024, driven by the increasing demand for accurate and comprehensive testing solutions. Centralized laboratories, primarily located in hospitals and diagnostic centers, offer advanced diagnostic capabilities, including ELISA and RT-PCR tests, which are essential for confirming dengue infections
  • Based on end use, the clinical labs segment dominated the market with a revenue share of 44.16% in 2024. Growth is driven by increased investments in laboratory automation, high?throughput ELISA, and RT?PCR platforms, enabling same?day turnaround.
  • In 2024, Asia Pacific led the global market with a share of 31.57%, owing to endemic dengue transmission in India, Indonesia, and Thailand. National vector control programs (e.g., India's NVBDCP) fund ELISA and RT?PCR in regional labs, while community health centers deploy POC NS1 rapid tests.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Service Type
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Service Type outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Dengue Testing Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Rising Incidence of Dengue
    • 3.4.2. Technological Advancements
    • 3.4.3. Government and International Initiatives
  • 3.5. Market Restraint Analysis
    • 3.5.1. High Cost of Diagnostic Tests
    • 3.5.2. Limited Access to Healthcare Infrastructure
    • 3.5.3. Porter's Five Forces Analysis
    • 3.5.4. PESTEL Analysis

Chapter 4. Dengue Testing Market: Product Estimates & Trend Analysis

  • 4.1. Dengue Testing Market: Product Movement Analysis
  • 4.2. Dengue Testing Market Estimates and Forecast, by Product
  • 4.3. ELISA-based Tests
    • 4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4. Dengue IgG/IgM Detection Kits
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. RT-PCR Tests
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Rapid Diagnostic Tests (RDTs)
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. NS1 Antigen Detection Kits
    • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Lateral Flow Immunoassay
    • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Dengue Testing Market: Service Type Estimates & Trend Analysis

  • 5.1. Dengue Testing Market: Service Type Movement Analysis
  • 5.2. Dengue Testing Market Estimates and Forecast, by Service Type
  • 5.3. Centralized Service
    • 5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4. POC Service
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Dengue Testing Market: End Use Estimates & Trend Analysis

  • 6.1. Dengue Testing Market: Distribution Movement Analysis
  • 6.2. Dengue Testing Market Estimates and Forecast, by End Use
  • 6.3. Clinical Labs
    • 6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4. Hospitals /Clinics
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Home Healthcare
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Dengue Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Dengue Testing Market Share By Region, 2024 & 2030
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. Regional Market Dashboard
  • 7.4. Global Regional Market Snapshot
  • 7.5. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.6. North America
    • 7.6.1. North America Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.6.2. U.S.
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. U.S. Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.6.3. Canada
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Canada Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.6.4. Mexico
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Mexico Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.7. Europe
    • 7.7.1. Europe Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.7.2. UK
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. UK Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.7.3. Germany
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Germany Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.7.4. France
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. France Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.7.5. Italy
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Italy Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.7.6. Spain
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Competitive Scenario
      • 7.7.6.3. Regulatory Framework
      • 7.7.6.4. Spain Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.7.7. Denmark
      • 7.7.7.1. Key Country Dynamics
      • 7.7.7.2. Competitive Scenario
      • 7.7.7.3. Regulatory Framework
      • 7.7.7.4. Denmark Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.7.8. Sweden
      • 7.7.8.1. Key Country Dynamics
      • 7.7.8.2. Competitive Scenario
      • 7.7.8.3. Regulatory Framework
      • 7.7.8.4. Sweden Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.7.9. Norway
      • 7.7.9.1. Key Country Dynamics
      • 7.7.9.2. Competitive Scenario
      • 7.7.9.3. Regulatory Framework
      • 7.7.9.4. Norway Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.8. Asia Pacific
    • 7.8.1. Asia Pacific Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.8.2. Japan
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Japan Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.8.3. China
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. China Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.8.4. India
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. India Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.8.5. Australia
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Australia Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.8.6. Thailand
      • 7.8.6.1. Key Country Dynamics
      • 7.8.6.2. Competitive Scenario
      • 7.8.6.3. Regulatory Framework
      • 7.8.6.4. Thailand Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.8.7. South Korea
      • 7.8.7.1. Key Country Dynamics
      • 7.8.7.2. Competitive Scenario
      • 7.8.7.3. Regulatory Framework
      • 7.8.7.4. South Korea Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.9. Latin America
    • 7.9.1. Latin America Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.9.2. Brazil
      • 7.9.2.1. Key Country Dynamics
      • 7.9.2.2. Competitive Scenario
      • 7.9.2.3. Regulatory Framework
      • 7.9.2.4. Brazil Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.9.3. Argentina
      • 7.9.3.1. Key Country Dynamics
      • 7.9.3.2. Competitive Scenario
      • 7.9.3.3. Regulatory Framework
      • 7.9.3.4. Argentina Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.10. MEA
    • 7.10.1. MEA Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.10.2. South Africa
      • 7.10.2.1. Key Country Dynamics
      • 7.10.2.2. Competitive Scenario
      • 7.10.2.3. Regulatory Framework
      • 7.10.2.4. South Africa Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.10.3. Saudi Arabia
      • 7.10.3.1. Key Country Dynamics
      • 7.10.3.2. Competitive Scenario
      • 7.10.3.3. Regulatory Framework
      • 7.10.3.4. Saudi Arabia Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.10.4. UAE
      • 7.10.4.1. Key Country Dynamics
      • 7.10.4.2. Competitive Scenario
      • 7.10.4.3. Regulatory Framework
      • 7.10.4.4. UAE Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.10.5. Kuwait
      • 7.10.5.1. Key Country Dynamics
      • 7.10.5.2. Competitive Scenario
      • 7.10.5.3. Regulatory Framework
      • 7.10.5.4. Kuwait Dengue Testing Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Strategy Mapping
  • 8.4. Company Market Share Analysis, 2024
  • 8.5. Company Profiles
    • 8.5.1. Thermo Fisher Scientific Inc.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Abbott
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. F. Hoffmann-La Roche Ltd.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. InBios International, Inc.
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. NovaTec Immundiagnostica GmbH
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Abnova Corporation
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. PerkinElmer Inc. (Euroimmun AG)
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Certest Biotec
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. DiaSorin S.p.A.
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Quest Diagnostics Incorporated
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 3 Global Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 4 Global Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 5 Global Dengue Testing Market, by Region, 2018 - 2030 (USD Million)
  • Table 6 North America Dengue Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 7 North America Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 8 North America Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 9 North America Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 11 U.S. Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 12 U.S. Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 13 Canada Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 14 Canada Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 15 Canada Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 16 Mexico Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 17 Mexico Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 18 Mexico Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 19 Europe Dengue Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 20 Europe Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 21 Europe America Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 22 Europe America Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 23 UK Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 24 UK Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 25 UK Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 26 Germany Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 27 Germany Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 28 Germany Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 29 France Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 30 France Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 31 France Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 32 Italy Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 33 Italy Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 34 Italy Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 35 Spain Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 36 Spain Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 37 Spain Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 38 Denmark Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 39 Denmark Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 40 Denmark Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 41 Sweden Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 42 Sweden Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 43 Sweden Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 44 Norway Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 45 Norway Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 46 Norway Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Dengue Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 51 Japan Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 52 Japan Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 53 Japan Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 54 China Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 55 China Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 56 China Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 57 India Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 58 India Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 59 India Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 60 Australia Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 61 Australia Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 62 Australia Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 63 Thailand Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 64 Thailand Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 65 Thailand Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 66 South Korea Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 67 South Korea Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 68 South Korea Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 69 Latin America Dengue Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 70 Latin America Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 71 Latin America Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 72 Latin America Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 73 Brazil Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 74 Brazil Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 75 Brazil Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 76 Argentina Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 77 Argentina Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 78 Argentina Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa Dengue Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Dengue Testing Market, by product, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 83 South Africa Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 84 South Africa Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 89 UAE Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 90 UAE Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 91 UAE Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Dengue Testing Market segmentation
  • Fig. 8 Market snapshot, 2024
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Dengue testing market: Product movement analysis
  • Fig. 15 Dengue testing market: Product outlook and key takeaways
  • Fig. 16 ELISA-based Tests market estimates and forecast, 2018 - 2030
  • Fig. 17 Dengue IgG/IgM Detection Kits market estimates and forecast, 2018 - 2030
  • Fig. 18 RT-PCR Tests market estimates and forecast, 2018 - 2030
  • Fig. 19 Rapid Diagnostic Tests (RDTs) market estimates and forecast, 2018 - 2030
  • Fig. 20 NS1 Antigen Detection Kits market estimates and forecast, 2018 - 2030
  • Fig. 21 Lateral Flow Immunoassay market estimates and forecast, 2018 - 2030
  • Fig. 22 Dengue testing market: Service Type movement analysis
  • Fig. 23 Dengue testing market: Service Type outlook and key takeaways
  • Fig. 24 Centralized Service market estimates and forecast, 2018 - 2030
  • Fig. 25 POC Service market estimates and forecast, 2018 - 2030
  • Fig. 26 Dengue testing market: End use movement analysis
  • Fig. 27 Dengue testing market: End use outlook and key takeaways
  • Fig. 28 Clinical Labs market estimates and forecast, 2018 - 2030
  • Fig. 29 Hospitals /Clinics market estimates and forecast, 2018 - 2030
  • Fig. 30 Home Healthcare market estimates and forecast, 2018 - 2030
  • Fig. 31 Government Suppliers market estimates and forecast, 2018 - 2030
  • Fig. 32 Others market estimates and forecast, 2018 - 2030
  • Fig. 33 Regional outlook, 2024 & 2030
  • Fig. 34 Global Dengue Testing Market: Region movement analysis
  • Fig. 35 North America Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 37 Canada Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 38 Mexico Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 40 Germany Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 41 UK Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 42 France Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 47 Norway Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 48 Asia Pacific Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 49 Japan Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 50 China Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 51 India Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 52 Australia Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 53 South Korea Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 54 Thailand Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 58 Middle East and Africa Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 61 UAE Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 62 Kuwait Dengue Testing Market, 2018 - 2030 (USD Million)